Onkologie. 2008:2(2):85-87

Combination of radiotherapy and chemotherapy in head and neck cancer treatment

Petr Burkoň
Oddělení klinické a radiační onkologie, FN u svaté Anny v Brně

Tumours of the head and neck region belong to the most often reasons of death for malignancies. There are approximatelly half million new cases per year found out all over the world. Sixty percent of these patients have advanced disease and their prognosis is very bad. If successfully treated such patients suffer from various functional or cosmetic disorders. Many changes in treatment of head and neck cancer come in the last few years. Previously used methods of care – surgery or radiotherapy alone – are today combined together or with other modalities of cancer care. The therapy of head and neck cancer is multidisciplinar nowadays. Chemotherapy becomes an important part of radiation therapy schedules, alternative fractionation or IMRT techniques (intensity modulated radiation therapy) are used. Quality of life is one of the most important factors changing doctors´ decision how to care each patient. The aim of new methods of care is to improve the efficacy but with keeping the toxicity in the same or low level.

Keywords: head and neck cancer, radiotherapy, induction chemotherapy, concurrent chemoradiotherapy

Published: August 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Burkoň P. Combination of radiotherapy and chemotherapy in head and neck cancer treatment. Onkologie. 2008;2(2):85-87.
Download citation

References

  1. Mechl Z, Neuwirtová J, Burkoň P et al. Současné možnosti léčby karcinomů hlavy a krku. Farmakoterapie, 2008; 157-165.
  2. Lefebvre JL, Chevalier D, Luboinski B et al. Is laryngeal preservation (LP) with induction chemotherapy (ICT) safe in the treatment of hypopharyngeal SCC? Final results of the phase III EORTC 24891 trial. Proc ASCO 2004; 22: Abstr. 5531. Go to original source...
  3. Paccagnella A, Orlando A, Marchiori C et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst. 1994 Feb 16; 86(4): 265-272. Go to original source... Go to PubMed...
  4. Domenge C, Hill C, Lefebvre JL et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d´Etude des Tumeurs de la Tete et du Cou (GETTEC). Br J cancer 2000; 86: 265-273. Go to original source... Go to PubMed...
  5. Vermorken JB, Remenar E, van Herpen C et al. Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer. N Engl J Med 2007; 357: 1695-1704. Go to original source... Go to PubMed...
  6. Posner MR, Hershock DM, Blajman CR et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Eng J Med 2007; 357: 1705-1715. Go to original source... Go to PubMed...
  7. Šlampa P. Přehled konkomitantní chemoradioterapie solidních nádorů. Čas Lék Čes 2003; 142 (Suppl. 1): 4-8.
  8. Vorlíček J, Vyzula R, Adam Z et al. Praktická onkologie. Vybrané kapitoly. 1. vydání. Praha: Grada, 2000, 344 s.
  9. Perez CA, Brady LW et al. Principles and Practice of Radiation Oncology. Lippincott Williams & Wilkins, Fourth Edition, Philadelphia 2004, 2527 s.
  10. Budach V. Current status of chemoradiation in head and neck cancer. Radiother Oncol 2002; 64(Suppl 1): S103. Go to original source...
  11. Browman GP, Cripps C, Hodson DI et al. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 1994; 12: 2648-2653. Go to original source... Go to PubMed...
  12. Calais G, Alfonsi M, Bardet E et al. Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma: final results of the 94-01 GORTEC randomized study. Int J Radiat Oncol Biol Phys 2001; 51(Suppl 1): S1. Go to original source...
  13. Adelstein DJ, Li Y, Adams GL et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21: 92-98. Go to original source... Go to PubMed...
  14. Al-Sarraf M, LeBlanc M, Giri PG et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 1998; 16: 1310-1317. Go to original source... Go to PubMed...
  15. Jeremic B, Shibamoto Y, Stanisavljevic B et al. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol 1997; 43: 29-37. Go to original source... Go to PubMed...
  16. Brizel DM, Albers MA, Fisher SR et al. Hyperfractionated irradiation with and without cocurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338: 1798-1804. Go to original source... Go to PubMed...
  17. Jeremic B, Shibamoto Y, Milicic B et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000; 18: 1458-1464. Go to original source... Go to PubMed...
  18. Budach VG, Dinges S, Haake K et al. Accelerated chemoradiation to 70,6 Gy is more effective than accelerated radiation to 77,6 Gy alone: two year results of a German multicenter randomized trial. Int J Radiat Oncol Biol Phys 2000; 48(Suppl 1): S150. Go to original source...
  19. Marmiroli L, Ausili-Cefaro G, Nardone L et al. Combined radiochemotherapy for organ preservation in head and neck cancer. Rays 1997; 33: 425-440.
  20. Forastiere AA, Goepfert H, Maor M et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098. Go to original source... Go to PubMed...
  21. Bernier J, Domenge C, Ozsahin M et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945-1952. Go to original source... Go to PubMed...
  22. Cooper JS, Pajak TF, Forastiere AA et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Eng J Med 2004; 350: 1937-1944. Go to original source... Go to PubMed...
  23. Bernier J, Cooper JS, Pajak TF et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (22931) and RTOG (9501). Head Neck 2005; 27: 843-850. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.